Clinical trials: Primary Focal Hyperhidrosis of the Hands

Primary Focal Hyperhidrosis of the Hands

BTX-A Treatment for Palmar Hyperhidrosis

• Terminated
• Age: 16 years and older
• Phase 2/3
• Injection or infusion
• Results posted

Primary focal hyperhidrosis (excessive sweating) is a debilitating condition affecting approximately 3% of the population in the United States.

Trial name

NCT01262339

Testing

BTX-A

Where

United States

Volunteers

2 people

Sponsor

University of Wisconsin, Madison